BlackRock Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $2.2M | Sell |
34,710
-1,598
| -4% | -$101K | ﹤0.01% | 1417 |
|
|
2016
Q3 | $2.31M | Sell |
36,308
-24,008
| -40% | -$1.53M | ﹤0.01% | 1356 |
|
|
2016
Q2 | $4.49M | Buy |
60,316
+1,781
| +3% | +$133K | ﹤0.01% | 1119 |
|
|
2016
Q1 | $3.91M | Sell |
58,535
-122
| -0.2% | -$8.15K | ﹤0.01% | 1163 |
|
|
2015
Q4 | $3.97M | Sell |
58,657
-10,591
| -15% | -$716K | ﹤0.01% | 1153 |
|
|
2015
Q3 | $3.7M | Sell |
69,248
-2,898
| -4% | -$155K | ﹤0.01% | 1172 |
|
|
2015
Q2 | $4.54M | Sell |
72,146
-29,051
| -29% | -$1.83M | ﹤0.01% | 998 |
|
|
2015
Q1 | $4.87M | Sell |
101,197
-14,700
| -13% | -$707K | 0.01% | 956 |
|
|
2014
Q4 | $3.85M | Buy |
115,897
+3,535
| +3% | +$117K | ﹤0.01% | 1020 |
|
|
2014
Q3 | $3.29M | Sell |
112,362
-189
| -0.2% | -$5.54K | ﹤0.01% | 1035 |
|
|
2014
Q2 | $4.37M | Buy |
112,551
+61,528
| +121% | +$2.39M | ﹤0.01% | 981 |
|
|
2014
Q1 | $2.14M | Buy |
51,023
+25,833
| +103% | +$1.08M | ﹤0.01% | 1143 |
|
|
2013
Q4 | $827K | Buy |
25,190
+2,187
| +10% | +$71.8K | ﹤0.01% | 1628 |
|
|
2013
Q3 | $621K | Sell |
23,003
-26,727
| -54% | -$722K | ﹤0.01% | 1735 |
|
|
2013
Q2 | $1.16M | Buy |
+49,730
| New | +$1.16M | ﹤0.01% | 1312 |
|